This article is more than 5 years old. Information may no longer be current.

VIDEO: No significant increase in IOP after Iluvien implant, studies find

ByJim C. Lai, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

HONOLULU — Jim C. Lai, MD, discusses safety data from the PALADIN and USER studies evaluating IOP rise after treatment with Iluvien (fluocinolone acetonide intravitreal implant, Alimera Sciences) at the Association for Research in Vision and Ophthalmology meeting here.